115 results
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Enters Into Cooperation Agreement With Engaged Capital
4:11pm
of chronic pain, today announced that it has entered into a Cooperation Agreement with Engaged Capital, LLC (“Engaged Capital”), pursuant to which Kirt P … for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
for the treatment of chronic pain, today reported its fourth-quarter and full-year 2023 financial results. The company also provided first-quarter … focus and dedication to freeing patients from the burden of chronic pain,” Thornal continued. “We are off to a solid start as we enter 2024
424B3
NVRO
Nevro Corp
10 Jan 24
Prospectus supplement
5:26pm
that continue to set the standard for enduring patient outcomes in chronic pain treatment. We have developed and commercialized our HFX™ spinal cord stimulation … (SCS) platform, which includes the Senza® SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza® HFX
8-K
EX-99.1
nxspv
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
S-3
y2pau5bim l2bsj45n
28 Dec 23
Shelf registration
6:40pm
8-K
EX-99.1
opw au754yc
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
hb8th
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
ox3hhd836
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
SD
EX-1.01
dq7s 4a1j0yd4zx
23 May 23
Conflict minerals disclosure
5:04pm
8-K
EX-99.1
d02jra7o
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
EX-99.1
w2taowje oz
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
4un1j9tzhv9l 96xih5
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm